Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral Effects.
DNA virus
RIG-I
RNA therapy
RNA virus
SARS-CoV-2
adenovirus
antiviral agents
influenza virus
interferon
short double-strand blunt-end RNA
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
28 06 2022
28 06 2022
Historique:
received:
09
05
2022
revised:
17
06
2022
accepted:
23
06
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Pathogen-associated molecular patterns, including cytoplasmic DNA and double-strand (ds)RNA trigger the induction of interferon (IFN) and antiviral states protecting cells and organisms from pathogens. Here we discovered that the transfection of human airway cell lines or non-transformed fibroblasts with 24mer dsRNA mimicking the cellular micro-RNA (miR)29b-1* gives strong anti-viral effects against human adenovirus type 5 (AdV-C5), influenza A virus X31 (H3N2), and SARS-CoV-2. These anti-viral effects required blunt-end complementary RNA strands and were not elicited by corresponding single-strand RNAs. dsRNA miR-29b-1* but not randomized miR-29b-1* mimics induced IFN-stimulated gene expression, and downregulated cell adhesion and cell cycle genes, as indicated by transcriptomics and IFN-I responsive Mx1-promoter activity assays. The inhibition of AdV-C5 infection with miR-29b-1* mimic depended on the IFN-alpha receptor 2 (IFNAR2) and the RNA-helicase retinoic acid-inducible gene I (RIG-I) but not cytoplasmic RNA sensors MDA5 and ZNFX1 or MyD88/TRIF adaptors. The antiviral effects of miR29b-1* were independent of a central AUAU-motif inducing dsRNA bending, as mimics with disrupted AUAU-motif were anti-viral in normal but not RIG-I knock-out (KO) or IFNAR2-KO cells. The screening of a library of scrambled short dsRNA sequences identified also anti-viral mimics functioning independently of RIG-I and IFNAR2, thus exemplifying the diverse anti-viral mechanisms of short blunt-end dsRNAs.
Identifiants
pubmed: 35891387
pii: v14071407
doi: 10.3390/v14071407
pmc: PMC9322957
pii:
doi:
Substances chimiques
Antiviral Agents
0
Interferon Type I
0
MicroRNAs
0
RNA, Double-Stranded
0
DEAD Box Protein 58
EC 3.6.4.13
DEAD-box RNA Helicases
EC 3.6.4.13
Banques de données
ClinicalTrials.gov
['NCT02735824']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Swiss National Science Foundation
ID : 31003A_179256 / 1
Pays : Switzerland
Organisme : Swiss National Science Foundation
ID : 51RT 0_126008
Pays : Switzerland
Références
Immunity. 2005 Aug;23(2):165-75
pubmed: 16111635
Nucleic Acids Res. 2014 Dec 16;42(22):e168
pubmed: 25300484
EMBO Rep. 2022 Feb 3;23(2):e54341
pubmed: 34914162
Nat Biotechnol. 2017 Apr;35(4):347-349
pubmed: 28263296
Mol Ther. 2012 May;20(5):948-53
pubmed: 22334017
Physiol Genomics. 2012 Feb 27;44(4):237-44
pubmed: 22214600
Nature. 2010 Feb 11;463(7282):818-22
pubmed: 20081832
J Virol. 2007 Oct;81(19):10540-9
pubmed: 17652395
J Cell Sci. 2020 Nov 9;134(5):
pubmed: 32917739
J Biol Chem. 2011 Feb 25;286(8):6108-16
pubmed: 21159780
Mol Ther. 2022 May 4;30(5):1850-1868
pubmed: 35189345
Nat Biotechnol. 2005 Apr;23(4):457-62
pubmed: 15778705
Cell Host Microbe. 2011 Aug 18;10(2):105-17
pubmed: 21843868
Nat Cell Biol. 2019 Nov;21(11):1346-1356
pubmed: 31685995
J Allergy Clin Immunol. 2021 Aug;148(2):381-393
pubmed: 33872655
Mol Cell. 2019 Oct 3;76(1):96-109.e9
pubmed: 31474572
BMC Genomics. 2014 Dec 22;15:1162
pubmed: 25534632
RNA. 2006 Oct;12(10):1790-3
pubmed: 16921069
Immunity. 2009 Jul 17;31(1):25-34
pubmed: 19576794
Front Mol Biosci. 2022 Apr 11;9:830161
pubmed: 35480881
Immunity. 2013 May 23;38(5):855-69
pubmed: 23706667
Nat Biotechnol. 2006 May;24(5):559-65
pubmed: 16648842
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17516-21
pubmed: 24101521
Cell Host Microbe. 2010 Jun 25;7(6):427-39
pubmed: 20542247
J Virol. 2013 Nov;87(22):12367-79
pubmed: 24027314
Nat Methods. 2006 Mar;3(3):199-204
pubmed: 16489337
J Med Virol. 2006 Jan;78(1):74-82
pubmed: 16299717
Nat Commun. 2017 Nov 27;8(1):1789
pubmed: 29176620
BMC Immunol. 2009 Jul 24;10:40
pubmed: 19630977
Cell Host Microbe. 2013 Mar 13;13(3):336-46
pubmed: 23498958
Cell Rep. 2019 Feb 19;26(8):2019-2027.e4
pubmed: 30784585
J Virol. 2019 Jun 28;93(14):
pubmed: 31043531
Front Genet. 2015 Dec 02;6:340
pubmed: 26697058
J Cell Physiol. 2012 Jun;227(6):2668-76
pubmed: 21898404
Biochem Pharmacol. 2021 Jan;183:114316
pubmed: 33152343
Microbes Infect. 2011 May;13(5):516-25
pubmed: 21276872
Mol Cell. 2017 Jul 20;67(2):214-227.e7
pubmed: 28625552
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4548-53
pubmed: 24616511
Cell Rep. 2019 Dec 17;29(12):3785-3795.e8
pubmed: 31851912
PLoS Pathog. 2018 May 21;14(5):e1007055
pubmed: 29782552
Q Rev Biophys. 2021 Jul 06;54:e8
pubmed: 34225835
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Virol. 2005 Aug;79(15):9556-65
pubmed: 16014917
Arch Virol. 2007;152(12):2137-57
pubmed: 17851732
Nucleic Acids Res. 2020 Dec 16;48(22):12917-12928
pubmed: 33245767
Microbiol Mol Biol Rev. 2004 Sep;68(3):432-52, table of contents
pubmed: 15353564
Cell. 2017 Jul 13;170(2):352-366.e13
pubmed: 28709002
Cell Death Dis. 2018 Feb 15;9(3):272
pubmed: 29449668
PLoS Comput Biol. 2013;9(9):e1003235
pubmed: 24068911
J Virol. 2015 Feb;89(3):1608-27
pubmed: 25410853
Nucleic Acids Res. 2022 Jan 11;50(1):333-349
pubmed: 34928377
Front Bioeng Biotechnol. 2022 Mar 02;10:801870
pubmed: 35309990
Mol Syst Biol. 2012 Apr 24;8:579
pubmed: 22531119
Mol Ther Nucleic Acids. 2019 Mar 1;14:509-519
pubmed: 30753994
Mol Microbiol. 2022 Apr 17;:
pubmed: 35434852
Cell. 1993 Nov 5;75(3):477-86
pubmed: 8221887
Nat Med. 2005 Mar;11(3):263-70
pubmed: 15723075
Cell Rep. 2012 Nov 29;2(5):1187-96
pubmed: 23142662
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
RNA. 2006 Jul;12(7):1179-87
pubmed: 16682560
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
Mol Cell. 2008 Feb 29;29(4):428-40
pubmed: 18242112
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Viruses. 2021 Aug 09;13(8):
pubmed: 34452433
Nat Rev Genet. 2008 Feb;9(2):102-14
pubmed: 18197166
J Virol. 2015 Aug;89(16):8318-33
pubmed: 26041291
PLoS Pathog. 2021 Jul 28;17(7):e1009759
pubmed: 34320031
EMBO Rep. 2013 Sep;14(9):772-9
pubmed: 23897087
Annu Rev Virol. 2019 Sep 29;6(1):567-584
pubmed: 31283436
Methods Mol Biol. 2007;356:319-50
pubmed: 16988414
Virology. 2011 Mar 15;411(2):325-43
pubmed: 21277611
Mol Ther Oncolytics. 2018 Dec 31;12:173-194
pubmed: 30788428
Annu Rev Immunol. 2019 Apr 26;37:349-375
pubmed: 30673536
Proc Natl Acad Sci U S A. 2021 Dec 28;118(52):
pubmed: 34903581
Annu Rev Immunol. 2001;19:623-55
pubmed: 11244049
Viruses. 2011 Jul;3(7):1112-30
pubmed: 21994773
Exp Biol Med (Maywood). 2016 Feb;241(4):409-20
pubmed: 26518627
PLoS One. 2013;8(1):e55214
pubmed: 23358900
Cell Mol Immunol. 2021 Mar;18(3):539-555
pubmed: 33462384
Nature. 2020 Jun;582(7813):561-565
pubmed: 32365353
J Virol. 2004 Dec;78(23):12868-76
pubmed: 15542639
J Biol Chem. 2000 Jun 16;275(24):18271-8
pubmed: 10751399
J Allergy Clin Immunol. 2019 Nov;144(5):1441-1445.e17
pubmed: 31419545
PLoS One. 2013 Jul 12;8(7):e68450
pubmed: 23874633
Nat Microbiol. 2021 Oct;6(10):1319-1333
pubmed: 34556855
Nat Rev Drug Discov. 2007 Dec;6(12):975-90
pubmed: 18049472
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4
pubmed: 16381832
Curr Res Virol Sci. 2022;3:100019
pubmed: 35072124
Mol Cell. 2022 Jan 6;82(1):30-43
pubmed: 34942118
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13830-5
pubmed: 20643939
Nature. 2007 Aug 16;448(7155):816-9
pubmed: 17653195
Cell Rep. 2021 Jan 12;34(2):108628
pubmed: 33440148
Nucleic Acids Res. 2010 Jan;38(3):750-63
pubmed: 19933264
Cell Host Microbe. 2015 Dec 9;18(6):723-35
pubmed: 26651948
Nature. 2007 May 10;447(7141):222-6
pubmed: 17495927
Sci Adv. 2018 Feb 21;4(2):e1701854
pubmed: 29492454
Front Genet. 2021 Jun 07;12:678994
pubmed: 34163530
Genome Biol. 2006;7(10):R100
pubmed: 17076895
Nat Microbiol. 2019 Jul;4(7):1075-1087
pubmed: 31160826
Eur J Immunol. 2006 May;36(5):1222-30
pubmed: 16609928
Nat Rev Immunol. 2020 Sep;20(9):537-551
pubmed: 32203325
Mol Ther Nucleic Acids. 2015 Sep 15;4:e252
pubmed: 26372022
J Mol Biol. 2022 Apr 15;434(7):167501
pubmed: 35183559